Editor’s Note: This is the first of an occasional GHN series examining the health challenges that the new Biden administration must confront in its first 100 days. The incoming Biden administration promises a vigorous, across-the-board reboot of the failed US…
A Chinese-made coronavirus vaccine has an efficacy rate just over 50%—far lower than the 78% anticipated, according to a Brazilian clinical trial conducted by São Paulo’s Butantan Institute.
In 2014, Detroit began turning off the taps of residents who couldn’t pay their water bills—most of them poor and Black. The pandemic has triggered a moratorium until 2022 on depriving water to those who can’t pay—but a permanent solution is still out of reach.
WHO investigators from 9 countries have arrived in Wuhan to look into the origins of the pandemic, following delays that triggered a rare rebuke from the agency.
The issue is far from settled among economists and politicians, as NPR repor
One Friday last month, I posted a map on Twitter. It drew immediate global attention, was seen by 8 million people, and has provoked strong responses and anger—and hopefully some soul-searching among those in governments and pharmaceutical companies.
For many detainees in US immigration facilities, the coronavirus was impossible to avoid. They were sleeping 3 feet apart with 36 people in a room.
Infectious new coronavirus variants spell bad news for already-strained hospitals, the WHO said yesterday,
Amid supply shortages and persistent vaccine nationalism, it could be years before COVID-19 vaccines reach billions of people in low- and middle-income countries, the
Reports that some low-priority staff at some elite medical institutions are getting coronavirus vaccines ahead of their turn are stirring an ethical outcry,